Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study

BACKGROUND: Immune modulating therapies are associated with an increased risk of infections and malignancies. This is of particular concern in elderly inflammatory bowel disease patients. This study aims to compare the safety and efficacy of vedolizumab between young and elderly inflammatory bowel d...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:United European Gastroenterol J
Autors principals: Cohen, Nathaniel Aviv, Plevris, Nikolas, Kopylov, Uri, Grinman, Anna, Ungar, Bella, Yanai, Henit, Leibovitzh, Haim, Isakov, Naomi Fliss, Hirsch, Ayal, Ritter, Einat, Ron, Yulia, Shitrit, Ariella Bar-Gil, Goldin, Eran, Dotan, Iris, Horin, Shomron Ben, Lees, Charlie W, Maharshak, Nitsan
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2020
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7724539/
https://ncbi.nlm.nih.gov/pubmed/32807038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640620951400
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars